24 studies found for:    "atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention: Drug: Eculizumab
2 Unknown  An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention: Drug: Eculizumab
3 Recruiting Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention:
4 Active, not recruiting Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
5 Recruiting Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Condition: Atypical Hemolytic Uraemic Syndrome.
Intervention:
6 Completed A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention:
7 Enrolling by invitation aHUS Observational Long Term Follow-Up
Condition: Atypical Hemolytic Uremic Syndrome
Intervention:
8 Active, not recruiting Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
9 Completed Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab
10 Completed Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab
11 Unknown  The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention: Drug: Eculizumab
12 Completed To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
Condition: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
Intervention:
13 Completed Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects
Conditions: Hemolytic-Uremic Syndrome;   Children;   Parents;   Psychological Adjustment
Intervention:
14 Completed Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
Conditions: Hemolytic-uremic Syndrome;   Escherichia Coli Infections
Intervention: Other: HUS standard coverage care (including in ICU)
15 Completed Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Condition: Hemolytic Uremic Syndrome
Intervention: Drug: SYNSORB Pk
16 Unknown  Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab
17 Completed The Role of Endothelium Dysfunction in Progression of CKD (Chronic Kidney Disease) After AKI (Acute Kidney Injury)
Conditions: Acute Renal Failure;   Chronic Kidney Failure;   Endothelial Dysfunction;   Hemolytic-uremic Syndrome (HUS)
Intervention:
18 Withdrawn The Plasma Large-Volume Exchange RCT
Conditions: Purpura, Thrombotic Thrombocytopenic;   Hemolytic Uremic Syndrome
Intervention: Procedure: Plasma Exchange
19 Terminated International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Conditions: Thrombotic Microangiopathy;   Hemolytic Uremic Syndrome;   Thrombotic Thrombocytopenic Purpura
Intervention:
20 Completed Safety and Efficacy Study of Eculizumab in Shiga-Toxin Producing Escherichia Coli Hemolytic-Uremic Syndrome (STEC-HUS)
Condition: Shiga-like Toxin-producing Escherichia Coli
Intervention: Drug: Eculizumab (Soliris®)

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years